An international clinical trial, led in the UK by Swansea’s Joint Clinical Research Facility (JCRF), has found that ...

aSchool of Artificial Intelligence and Information Technology, Nanjing University of Chinese Medicine, Nanjing, China bJiangsu Province Engineering Research Center of TCM Intelligence Health Service, ...

Novo Nordisk jumps 5% as Parvus Asset Management builds a stake to sway CEO succession amid leadership shakeup and pipeline ...

Sending letters to encourage guideline-directed practice in the management of chronic kidney disease to either patients or ...

The diabetic nephropathy market is driven by the growing burden of diabetes and the increasing demand for effective treatments for kidney disease. Advances in therapeutics, including new drug classes ...

Don’t be persuaded by the abundance of propaganda you see in ads, newspapers, magazines, TV, and the Internet. There is no ...

BEIJING--(BUSINESS WIRE)--Novo Holdings, a leading global life science investor, and KKR, a leading global investment firm, today announced the signing of definitive agreements under which Novo ...

During a session at the Heart in Diabetes CME Conference, speakers highlighted four papers recently published in Circulation ...

Adults with chronic kidney disease and type 2 diabetes had slower kidney function decline with a combination of the ...

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...